1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Catheter Precision, Inc.

Catheter Precision, Inc.

VTAK
Catheter Precision, Inc.US flagNew York Stock Exchange American
0.39
USD
-0.10
- -
421,385.00Market Cap

Total Valuation

Catheter Precision, Inc. carries a market capitalization of 421,385.00, placing it among publicly traded companies globally. Its enterprise value stands at 12.56M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap421,385.00
Enterprise Value12.56M

Share Statistics

Catheter Precision, Inc. currently has 2.69M shares outstanding.

Shares Outstanding2.69M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 1.28, and the price-to-book ratio stands at 0.00.

PE RatioN/A
PS Ratio1.28
PB Ratio0.00
P/TBV Ratio-0.06
P/FCF Ratio-0.17
P/OCF Ratio-0.16

Enterprise Valuation

EV / Sales11.34
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

Catheter Precision, Inc. maintains a current ratio of 0.06, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 130.98, indicating elevated leverage, while an interest coverage ratio of -25.58 demonstrates limited ability to service its debt obligations.

Current Ratio0.06
Quick Ratio0.04
Debt / Equity130.98
Debt / EBITDA-1.34
Interest Coverage-25.58

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-49.49
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.41

Taxes

Income Tax-1.26M
Effective Tax RateN/A

Stock Price Statistics

Catheter Precision, Inc.'s stock has declined approximately -90.86651% over the past 52 weeks. The 50-day moving average sits at 0.87, while the 200-day moving average is 1.57.

Beta (5Y)N/A
52-Week Price Change-90.86651%
50-Day Moving Average0.87
200-Day Moving Average1.57
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Catheter Precision, Inc. generated 1.11M in revenue and converted that into -14.82M in net income, yielding earnings per share of -10.92. EBITDA reached -8.98M, while operating income came in at -11.04M.

Revenue1.11M
Gross Profit1.01M
Operating Income-11.04M
Pretax Income-16.60M
Net Income-14.82M
EBITDA-8.98M
EBIT-11.04M
Earnings Per Share (EPS)-10.92

Balance Sheet

Catheter Precision, Inc. holds 441,000.00 in cash and equivalents against 11.99M in total debt, resulting in a net debt position of 9.92M. Total book value stands at -311.22M, with working capital of -18.49M providing operational flexibility.

Cash & Cash Equivalents441,000.00
Total Debt11.99M
Net Debt9.92M
Equity (Book Value)-311.22M
Book Value Per Share-221.54
Working Capital-18.49M

Cash Flow

Catheter Precision, Inc. produced -8.75M in operating cash flow over the past twelve months. After subtracting -232,000.00 in capital expenditures, free cash flow totaled -8.99M - equivalent to -6.40 per share.

Operating Cash Flow-8.75M
Capital Expenditures-232,000.00
Free Cash Flow-8.99M
FCF Per Share-6.40

Margins

Catheter Precision, Inc. operates with a gross margin of 91.52, reflecting its pricing power and cost economics. The operating margin of -996.66 and net profit margin of -1,337.45 provide insight into operational efficiency.

Gross Margin91.52
Operating Margin-996.66
Pretax Margin-1,498.29
Profit Margin-1,337.45
EBITDA Margin-810.47

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-696.85
FCF Yield-600.64

Stock Splits

Catheter Precision, Inc.'s most recent stock split took place on August 15, 2025 with a 19:1 split ratio.

Last Split Date8/15/2025
Split Ratio19:1

Scores

Catheter Precision, Inc. posts an Altman Z-Score of -160.89, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-160.89